PUNE: The Maharashtra authorities has despatched a considerable variety of samples from numerous districts for genome sequencing to confirm if any new mutation of SARS-CoV-2 has taken place, with the goal being to establish new COVID-19 variant Delta Plus or AY.1, an official stated right here on Monday.
The extremely transmissible Delta variant of SARS-CoV-2 has mutated additional to type the Delta Plus or AY.1 variant and it’s stated to be proof against the monoclonal antibody cocktail remedy for COVID-19 just lately licensed in India, he added.
“Now we have despatched substantial samples from numerous districts to analyze if there may be any prevalence of Delta-plus ( or AY.1). The studies are anticipated to come back by Tuesday,” stated Dr.
Pradip Awate, State Surveillance Officer.
He stated the state’s Directorate of Medical Schooling and Analysis (DMER) had signed an MOU with CSIR-Institute of Integrative and Genomic Biology (IGIB) beneath which BJ Medical right here would be the nodal lab to carry out genome sequencing of the samples.
In its newest report on coronavirus variants, up to date until final Friday, the well being company stated Delta Plus was current in six genomes from India as of June 7.
ALSO WATCH:
